Calvin Sandra bought TVTX

September 15, 2026 · Form 4 insider transaction

Calvin Sandra bought 2,500 shares of Travere Therapeutics, Inc. at $27.50 per share, a transaction worth $68.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.